Study of bronchiectasis severity and flare-up risk
Part of Lungs & breathing clinical trials.
This study helps doctors understand how severe your bronchiectasis is and predict when you might have flare-ups. You'll have routine tests over 12 months to help researchers learn more about this condition and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with non-cystic fibrosis bronchiectasis (damaged airways not caused by CF) confirmed by a CT scan
- You can visit Assiut University Hospitals for clinic visits or are already a patient there
- You are willing and able to complete tests (breathing tests, blood work, imaging) over 12 months
- You do not have cystic fibrosis, active tuberculosis, or a serious illness that would prevent you from completing the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps doctors identify different types of bronchiectasis (a lung disease where airways are permanently widened and damaged) to better understand how the disease develops and progresses. By following patients over time and collecting medical information, researchers hope to create a system that predicts which patients will worsen and need different treatments.
This study tests whether a common antibiotic called azithromycin can help prevent flare-ups (sudden worsening) of bronchiectasis—a lung condition where airways become permanently enlarged and damaged. Patients will take azithromycin or a placebo for 12 months to see if it reduces how often they get sick.
This study looks at different types of bronchiectasis in Chinese patients to understand the disease better. It may involve additional tests like lung function and questionnaires.
This study looks at how other health conditions and the severity of a bronchiectasis flare-up affect recovery in adults. It aims to understand what factors lead to better or worse outcomes during a flare-up.
This study looks at how bacteria live in the lungs of people with bronchiectasis and how they may adapt over time. It may help researchers understand why infections keep coming back and how to better manage chronic lung colonization.
This trial tests an inhaled medication called CSL787 to see if it can help people with non-cystic fibrosis bronchiectasis (a lung condition that causes frequent infections and breathing problems). The study looks at different doses and checks how well the drug works and if it is safe.
Hear when a new Bronchiectasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.